A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV.

Clinical trial NCT06979180 · RECRUITING

Trial details

NCT number: NCT06979180
Sponsor: Papillex Inc.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

CIN - Cervical Intraepithelial Neoplasia CIN 1 CIN 2 HPV Cervical Cells

Start date: 2026-03-01
Primary completion: 2026-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.